Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03112863 · ClinicalTrials.gov registry record · Early Phase 1

Comparison of the Cosmetic Effects of Bakuchiol and Retinol

A Early Phase 1 study of Wrinkle and Photoaging, sponsored by University of California, Davis.

Completed
Registry status
Early Phase 1
Development phase
44
Enrollment target
1
Study location

NCT03112863 is a Early Phase 1 study of Wrinkle and Photoaging that has completed, run by University of California, Davis. The registered enrollment target is 44 participants, below the 118-participant average among 25 other Wrinkle trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03112863, a Early Phase 1 study of Wrinkle and Photoaging, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
Early Phase 1
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

Subjects will be assigned to a retinoid cream or bakuchiol to compare the cosmetic effects. This will take place over a 12 week period.

Conditions Studied

Interventions

  • DRUG Bakuchiol
  • DRUG Retinol

Study Locations (1)

California

  • UC Davis Department of Dermatology - Sacramento

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2017-03-24
Est. Completion 2019-03-01
Phase Early Phase 1

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03112863

The ClinicalTrials.gov registry entry for NCT03112863 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 118-participant average among 25 other Wrinkle trials with a reported enrollment target (63% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Wrinkle appearing as the primary indexed condition, and to 2 interventions - of which Bakuchiol is the first listed.

NCT03112863 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03112863 about?

NCT03112863 is a clinical study titled "Comparison of the Cosmetic Effects of Bakuchiol and Retinol". Subjects will be assigned to a retinoid cream or bakuchiol to compare the cosmetic effects. This will take place over a 12 week period.

What is the current status of trial NCT03112863?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 44 participants. The study started on 2017-03-24. Estimated completion is 2019-03-01.

What conditions does trial NCT03112863 study?

This clinical trial studies the following conditions: Wrinkle, Photoaging.

What interventions are being tested in trial NCT03112863?

The interventions under investigation include: Bakuchiol (DRUG), Retinol (DRUG).

Who is sponsoring clinical trial NCT03112863?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03112863 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.